Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.57 USD
−34.36 M USD
0.00 USD
5.64 M
About CalciMedica, Inc.
Sector
Industry
CEO
Rachel Anne Leheny
Website
Headquarters
La Jolla
Founded
2007
FIGI
BBG0088HHJ97
CalciMedica, Inc. operates as a biopharmaceutical company. It focuses on developing therapies for life-threatening inflammatory diseases. The firm's product candidate Auxora helps in treating acute pancreatitis and asparaginase-associated pancreatitis. The company was founded by Kenneth A. Stauderman and Gonul Velicelebi in 2007 and is headquartered in La Jolla, CA.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of CALC is 3.45 USD — it hasn't changed in the past 24 hours. Watch CalciMedica, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange CalciMedica, Inc. stocks are traded under the ticker CALC.
CALC stock has risen by 1.77% compared to the previous week, the month change is a −14.71% fall, over the last year CalciMedica, Inc. has showed a −1.15% decrease.
We've gathered analysts' opinions on CalciMedica, Inc. future price: according to them, CALC price has a max estimate of 20.00 USD and a min estimate of 12.00 USD. Watch CALC chart and read a more detailed CalciMedica, Inc. stock forecast: see what analysts think of CalciMedica, Inc. and suggest that you do with its stocks.
CALC reached its all-time high on Jun 14, 2023 with the price of 8.59 USD, and its all-time low was 1.00 USD and was reached on Apr 3, 2023. View more price dynamics on CALC chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
CALC stock is 2.05% volatile and has beta coefficient of −0.84. Track CalciMedica, Inc. stock price on the chart and check out the list of the most volatile stocks — is CalciMedica, Inc. there?
Today CalciMedica, Inc. has the market capitalization of 46.51 M, it has increased by 3.60% over the last week.
Yes, you can track CalciMedica, Inc. financials in yearly and quarterly reports right on TradingView.
CalciMedica, Inc. is going to release the next earnings report on Mar 27, 2025. Keep track of upcoming events with our Earnings Calendar.
CALC earnings for the last quarter are −0.50 USD per share, whereas the estimation was −0.56 USD resulting in a 11.11% surprise. The estimated earnings for the next quarter are −0.44 USD per share. See more details about CalciMedica, Inc. earnings.
CalciMedica, Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
CALC net income for the last quarter is −5.62 M USD, while the quarter before that showed −3.95 M USD of net income which accounts for −42.08% change. Track more CalciMedica, Inc. financial stats to get the full picture.
No, CALC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 24, 2024, the company has 14.00 employees. See our rating of the largest employees — is CalciMedica, Inc. on this list?
Like other stocks, CALC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CalciMedica, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CalciMedica, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CalciMedica, Inc. stock shows the strong sell signal. See more of CalciMedica, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.